A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer
PurposeColon cancer (CC) is a serious disease burden. The prognosis of patients with CC is different, so looking for effective biomarkers to predict prognosis is vitally important. Ferroptosis is a promising therapeutic and diagnosis strategy in CC. However, the role of ferroptosis in prognosis of C...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.654076/full |
id |
doaj-70b119d37ed24be9ae40362e380718b5 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jianhua Nie Dan Shan Shun Li Shuyuan Zhang Xiaolin Zi Fan Xing Jiaqi Shi Caiqi Liu Tianjiao Wang Xiaoyuan Sun Qian Zhang Meng Zhou Shengnan Luo Hongxue Meng Yanqiao Zhang Tongsen Zheng Tongsen Zheng Tongsen Zheng |
spellingShingle |
Jianhua Nie Dan Shan Shun Li Shuyuan Zhang Xiaolin Zi Fan Xing Jiaqi Shi Caiqi Liu Tianjiao Wang Xiaoyuan Sun Qian Zhang Meng Zhou Shengnan Luo Hongxue Meng Yanqiao Zhang Tongsen Zheng Tongsen Zheng Tongsen Zheng A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer Frontiers in Oncology ferroptosis prognosis colon cancer STING immune status |
author_facet |
Jianhua Nie Dan Shan Shun Li Shuyuan Zhang Xiaolin Zi Fan Xing Jiaqi Shi Caiqi Liu Tianjiao Wang Xiaoyuan Sun Qian Zhang Meng Zhou Shengnan Luo Hongxue Meng Yanqiao Zhang Tongsen Zheng Tongsen Zheng Tongsen Zheng |
author_sort |
Jianhua Nie |
title |
A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer |
title_short |
A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer |
title_full |
A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer |
title_fullStr |
A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer |
title_full_unstemmed |
A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon Cancer |
title_sort |
novel ferroptosis related gene signature for prognosis prediction in patients with colon cancer |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-05-01 |
description |
PurposeColon cancer (CC) is a serious disease burden. The prognosis of patients with CC is different, so looking for effective biomarkers to predict prognosis is vitally important. Ferroptosis is a promising therapeutic and diagnosis strategy in CC. However, the role of ferroptosis in prognosis of CC has not been studied. The aim of the study is to build a prognosis model related ferroptosis, and provide clues for further therapy of CC.MethodsThe RNA-seq data were from TCGA (training group) and GEO (testing group). The R language and Perl language were used to process and analyze data. LASSO regression analysis was used to build the prognosis model. ssGSEA was used to compare the immune status between two groups. Immunohistochemistry was used to detect expression of AKR1C1 and CARS1 in colon cancer tissues and adjacent tissues.ResultsThe prognosis model consisted of five ferroptosis related genes (AKR1C1, ALOX12, FDFT1, ATP5MC3, and CARS1). The area under curve (AUC) at 1-, 2-, and 3-year were 0.668, 0.678, and 0.686, respectively. The high- and low-risk patients had significant survival probability and could be clearly distinguished by the PCA and t-SNE analysis. The multivariate cox regression analysis also showed the riskscore is an independent prognosis factor. Importantly, we found that the immune status between high- and low-risk patients were different obviously, such as CD8+T cells. And STING, a new promising immune target, was also correlated to our signature genes statistically significantly.ConclusionOur ferroptosis prognosis signature could predict survival of CC patients to a certain degree. And the crosstalk between ferroptosis and immune, especially STING need further studies. |
topic |
ferroptosis prognosis colon cancer STING immune status |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2021.654076/full |
work_keys_str_mv |
AT jianhuanie anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT danshan anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT shunli anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT shuyuanzhang anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT xiaolinzi anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT fanxing anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT jiaqishi anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT caiqiliu anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT tianjiaowang anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT xiaoyuansun anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT qianzhang anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT mengzhou anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT shengnanluo anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT hongxuemeng anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT yanqiaozhang anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT tongsenzheng anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT tongsenzheng anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT tongsenzheng anovelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT jianhuanie novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT danshan novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT shunli novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT shuyuanzhang novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT xiaolinzi novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT fanxing novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT jiaqishi novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT caiqiliu novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT tianjiaowang novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT xiaoyuansun novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT qianzhang novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT mengzhou novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT shengnanluo novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT hongxuemeng novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT yanqiaozhang novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT tongsenzheng novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT tongsenzheng novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer AT tongsenzheng novelferroptosisrelatedgenesignatureforprognosispredictioninpatientswithcoloncancer |
_version_ |
1721452920427249664 |
spelling |
doaj-70b119d37ed24be9ae40362e380718b52021-05-11T06:56:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-05-011110.3389/fonc.2021.654076654076A Novel Ferroptosis Related Gene Signature for Prognosis Prediction in Patients With Colon CancerJianhua Nie0Dan Shan1Shun Li2Shuyuan Zhang3Xiaolin Zi4Fan Xing5Jiaqi Shi6Caiqi Liu7Tianjiao Wang8Xiaoyuan Sun9Qian Zhang10Meng Zhou11Shengnan Luo12Hongxue Meng13Yanqiao Zhang14Tongsen Zheng15Tongsen Zheng16Tongsen Zheng17Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Radiation Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaThe Seventh Department of the Internal Medicine, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Phase 1 Trials Center, Harbin Medical University Cancer Hospital, Harbin, ChinaKey Laboratory of Molecular Oncology, Heilongjiang Cancer Institute, Harbin, ChinaPurposeColon cancer (CC) is a serious disease burden. The prognosis of patients with CC is different, so looking for effective biomarkers to predict prognosis is vitally important. Ferroptosis is a promising therapeutic and diagnosis strategy in CC. However, the role of ferroptosis in prognosis of CC has not been studied. The aim of the study is to build a prognosis model related ferroptosis, and provide clues for further therapy of CC.MethodsThe RNA-seq data were from TCGA (training group) and GEO (testing group). The R language and Perl language were used to process and analyze data. LASSO regression analysis was used to build the prognosis model. ssGSEA was used to compare the immune status between two groups. Immunohistochemistry was used to detect expression of AKR1C1 and CARS1 in colon cancer tissues and adjacent tissues.ResultsThe prognosis model consisted of five ferroptosis related genes (AKR1C1, ALOX12, FDFT1, ATP5MC3, and CARS1). The area under curve (AUC) at 1-, 2-, and 3-year were 0.668, 0.678, and 0.686, respectively. The high- and low-risk patients had significant survival probability and could be clearly distinguished by the PCA and t-SNE analysis. The multivariate cox regression analysis also showed the riskscore is an independent prognosis factor. Importantly, we found that the immune status between high- and low-risk patients were different obviously, such as CD8+T cells. And STING, a new promising immune target, was also correlated to our signature genes statistically significantly.ConclusionOur ferroptosis prognosis signature could predict survival of CC patients to a certain degree. And the crosstalk between ferroptosis and immune, especially STING need further studies.https://www.frontiersin.org/articles/10.3389/fonc.2021.654076/fullferroptosisprognosiscolon cancerSTINGimmune status |